These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 36907701)

  • 1. Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.
    Paul PK; Das R; Drow T; Nylen EA; de Souza AH; Wang Z; Wood MW; Davis DB; Bjorling DE; Galipeau J
    Am J Transplant; 2022 Nov; 22(11):2571-2585. PubMed ID: 35897156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft.
    Jalili RB; Forouzandeh F; Rezakhanlou AM; Hartwell R; Medina A; Warnock GL; Larijani B; Ghahary A
    Diabetes; 2010 Sep; 59(9):2219-27. PubMed ID: 20522587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
    Batra L; Shrestha P; Zhao H; Woodward KB; Togay A; Tan M; Grimany-Nuno O; Malik MT; Coronel MM; García AJ; Shirwan H; Yolcu ES
    J Immunol; 2020 May; 204(10):2840-2851. PubMed ID: 32253240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression" [American Journal of Transplantation (2022) 2571-2585].
    Paul PK; Das R; Drow T; Nylen EA; Henrique de Souza A; Wang Z; Wood MW; Davis DB; Bjorling DE; Galipeau J
    Am J Transplant; 2023 May; 23(5):693. PubMed ID: 36907701
    [No Abstract]   [Full Text] [Related]  

  • 7. Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
    Truong W; Hancock WW; Anderson CC; Merani S; Shapiro AM
    Cell Transplant; 2006; 15(2):105-19. PubMed ID: 16719045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of indoleamine 2,3-dioxygenase in transplantation.
    Hainz U; Jürgens B; Heitger A
    Transpl Int; 2007 Feb; 20(2):118-27. PubMed ID: 17239019
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.